Caffeine for heart stability in preterm babies
Part of Lungs & breathing clinical trials.
This trial tests whether caffeine therapy helps keep the heart and blood pressure stable in premature babies being treated for pauses in breathing (apnea of prematurity). Doctors want to see if caffeine is safe and effective for supporting heart function in the NICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 37 weeks of pregnancy (preterm).
- Your baby is receiving or about to receive caffeine therapy for apnea (pauses in breathing).
- Your baby's heart and blood pressure are stable before starting caffeine.
- Your baby does not have any major birth defects.
- Your baby is not on strong blood pressure medications (vasopressors) at the start.
- Your baby does not have a severe brain bleed (grade 3 or 4 intraventricular hemorrhage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving caffeine citrate can help prevent breathing pauses (apnea) in preterm babies who are ready to stop their current caffeine treatment. It aims to see if a short course of caffeine can keep babies stable after they come off oxygen and are eating well.
This study uses EEG brain scans to find the best time to stop caffeine treatment in premature babies. Caffeine is given to help with breathing, and the goal is to see if brain activity can guide when to safely stop it.
This trial tests whether giving caffeine citrate early to very preterm babies (born before 32 weeks) can improve their breathing and overall health. It's for babies who need caffeine anyway as part of their care, and it looks at short- and long-term benefits.
This study tests if giving an extra dose of caffeine (a medicine that helps premature babies breathe) right before removing the breathing tube can make the transition easier. It is for very premature babies who have been on a ventilator for at least two days and are ready for their first try at breathing on their own.
This study looks at how caffeine is absorbed and transferred to a baby during pregnancy in women at risk of early delivery. Researchers hope to understand safe caffeine use in this situation and potentially help prevent complications.
This trial looks at using a tiny amount of blood from a heel prick or similar method to measure caffeine levels in premature babies. The goal is to make monitoring caffeine treatment easier and less stressful for newborns.
Hear when a new Apnea of Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.